EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Protein–glycan engineering in vaccine design: merging immune mechanisms with biotechnological innovation

Maxwell Kearns, Mengwan Li, Asher J Williams

Trends in Biotechnology · 2026

DOI: 10.1016/j.tibtech.2025.06.022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2026. Verfasst von Maxwell Kearns und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Columbia University, New York, NY 10027, USA. Hauptthemen laut MEDLINE: Polysaccharides, Biotechnology, Protein Engineering, Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 117 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycans are critical regulators of immune recognition, influencing pathogen detection and immune modulation. Despite their potential in vaccine design, challenges, such as glycan heterogeneity and immune evasion, persist. Recent advances in protein-glycan engineering, spanning clustered regularly interspaced short palindromic repeats (CRISPR)-based glycoediting, synthetic biology, and glycan-modified nanoparticles (NPs), are now enabling precise control of glycan structures to enhance antigen presentation and immune activation. These innovations improve antigen stability, optimize immune responses, and expand vaccine targets to emerging pathogens, tumors, and autoimmune disorders. Computational tools further refine glycan engineering for rational vaccine design. In this review, by providing essential immunological context on glycan-mediated mechanisms in infection, cancer, and autoimmunity, we highlight how integrating cutting-edge biotechnologies with protein-glycan research is redefining vaccine efficacy and informing the development of next-generation glycoengineered vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesBiotechnologyProtein EngineeringVaccinesVaccine DevelopmentHumansAnimals

Stichwörter der Autor:innen

glycoengineeringimmune evasionnanoparticle delivery systemsprotein–glycan interactionssynthetic biologyvaccine development

Substanzen

PolysaccharidesVaccines

Autor:innen und Institutionen

  • Department of Chemical Engineering, Columbia University, New York, NY 10027, USA.
  • Department of Chemical Engineering, Columbia University, New York, NY 10027, USA. Electronic address: aw3571@columbia.edu.

Zitieren

APA

Kearns, M., Li, M., & Williams, A. J. (2026). Protein–glycan engineering in vaccine design: merging immune mechanisms with biotechnological innovation. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2025.06.022

Vancouver

Kearns M, Li M, Williams AJ. Protein–glycan engineering in vaccine design: merging immune mechanisms with biotechnological innovation. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2025.06.022

BibTeX
@article{Kearns2026,
  author = {Kearns, Maxwell and Li, Mengwan and Williams, Asher J},
  title = {Protein–glycan engineering in vaccine design: merging immune mechanisms with biotechnological innovation},
  journal = {Trends in Biotechnology},
  year = {2026},
  doi = {10.1016/j.tibtech.2025.06.022}
}
Kostenlos starten →